NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries
This platform integrates the latest advancements in sequencing and genomic mapping technologies, combining the strengths of industry leaders such as Illumina, PacBio, Nanopore, and Bionano.
- This platform integrates the latest advancements in sequencing and genomic mapping technologies, combining the strengths of industry leaders such as Illumina, PacBio, Nanopore, and Bionano.
- The thorough and precise preparation of samples is critical in achieving reliable, high-quality data from next-generation sequencing, which in turn supports robust scientific conclusions.
- Optical Mapping Expertise: Through state-of-the-art Bionano Saphyr optical mapping technology, NewBiologix bridges gaps in sequence information, facilitating accurate genome assembly and analysis.
- For more information about NewBiologix and its next-generation sequencing and optical mapping platform, please visit newbiologix.com.